AbilityPharma Announces € 7 Million Financing Round to Advance Development of its Clinical Phase 2b

202220232024

Mar 11

Written By Guest User

Guest User

Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca

Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards